Tooling Solutions Sell Sheet

Controlling tooling in-house isn't just a manufacturing preference—it's a strategic advantage that directly affects part quality, lead times, and total program cost. For medical device and life sciences manufacturers, the ability to move from design optimization through prototype, validation, and full-scale production without handing off tooling responsibility changes the economics and timeline of product development significantly.

A structured four-step build process, precision inspection capabilities accurate to 5 microns, and access to a full range of SPI mold classes (101 through 105) mean that tooling decisions can be matched precisely to production volume requirements—whether that's a few thousand parts or over a million. Proprietary bridge tooling options offer a practical path for low- to mid-volume production that traditional prototyping can't support.

Download the full PDF to see how tooling strategy, material selection, and cavitation options map across production scenarios—and what that means for your program's timeline and budget.